- Search results for F0016-18.100
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
9 products were found matching "F0016-18.100"!
Close filters
Filter by:
No results were found for the filter!
Item number: F0018-18.100
Activation of the zymogen, factor X, by either the intrinsic or extrinsic factor Xase complexes produces the active serine protease factor Xa (1,2). The activation of factor X requires proteolytic cleavage of the heavy chain, resulting in the release of an activation glycopeptide. The heavy chain region in factor Xa...
MW: | 46,000 |
355.00€
*
Item number: F0016-10.100
Applications: , Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Extinction Coefficient: E1%, 1cm, 280nm = 14.0, Specific Activity: 1960BU/mg, Storage and Stability: May be stored at 4°C for short-term only....
Keywords: | Anti-F8, Anti-F8C, Anti-AHF, Anti-Antihemophilic factor, Anti-Procoagulant component, Anti-Coagulation factor VIII |
Application: | ELISA, WB |
Host: | Sheep |
Species reactivity: | human |
From 341.00€
*
Item number: F0016-02.100
Factor VIII (formerly referred to as antihemophilic globulin and Factor VIIIc) is a large glycoprotein (320kD) that circulates in plasma at approximately 200ng/ml. Synthesized in the liver, the majority of Factor VIII is cleaved during expression resulting in a heterogeneous mixture of partially cleaved forms of...
Keywords: | Anti-F8, Anti-Cf8, Anti-Procoagulant component, Anti-Coagulation factor VIII |
Application: | ELISA, WB |
Host: | Rat |
Species reactivity: | mouse |
667.00€
*
Item number: F0018-61.100
Human Factor XI is a plasma glycoprotein which circulates in a non-covalent complex with high molecular weight kininogen. The mature molecule is synthesized in the liver. It is a two-chain homodimer with a molecular weight of ~160kD. It is estimated that 5% of the total mass is attributable to carbohydrate. The two...
Application: | ELISA, RIA, WB |
Host: | Mouse |
Species reactivity: | human |
454.00€
*
Item number: F0017-18.100
Factor IXa with the active site irreversibly blocked by the fluorescent inhibitor, Dansyl-EGRck., Factor IXa is also available with the active site irreversibly blocked by the tripeptide chloromethyl ketone, EGRck. Activation of Factor X By Factor IXa: The intrinsic factor Xase complex consists of an enzyme, factor...
MW: | 4500 D |
337.00€
*
Item number: F0018-16.100
Factor Xa is a serine protease produced by the activation of the zymogen FactorX by either the intrinsic or extrinsic Factor Xase complexes. Factor Xa is involved in the prothrombinase complex, which catalyzes the rapid conversion of prothrombin to thrombin. Its structure cosists of 2 subunits, Mr: 16,500 and...
MW: | 46.00 kD |
311.00€
*
Item number: F0018-01.100
Human Factor X is a vitamin K-dependent protein zymogen which is synthesized in the liver and circulates in plasma as a two chain molecule linked by a disulfide bond (1,2). Prior to secretion into plasma, post-translational modifications produce 11 gamma-carboxyglutamic acid (gla) residues and a single...
MW: | 58.90 kD |
349.00€
*
Item number: F0018-21.100
Factor Xa with the active site irreversibly blocked by the fluorescent inhibitor, Dansyl-EGRck., Several modified forms of factor Xa are also available including: A) active-site blocked factor Xa containing the tripeptide chloromethyl ketone inhibitor EGRck, and B) human Gla-domainless b-factor Xa. Participation of...
MW: | 4530 D |
327.00€
*